Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare
Travere Therapeutics Inc. Price to FCF Ratio 2012–2026
Price to free cash flow (P/FCF) ratio for Travere Therapeutics Inc. (TVTX): market cap divided by trailing twelve-month free cash flow. As of September 30, 2018 it is 181.52.
From: 08/31/2011To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Travere Therapeutics Inc. Price to FCF Ratio — FAQ
Travere Therapeutics Inc. (TVTX) price to fcf ratio over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TVTX's price to fcf ratio history?
The chart and table above show Travere Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.